Financials
Financial year 2024
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ 89,721
▲ 128% vs 2023
Profit
Caution€ -175,235
▲ 40% vs 2023
Debts
Low€ 4.5 million
▲ 2567% vs 2023
EU BIOTECH CAMPUS from Charleroi, company number BE0776668706, closed financial year 2024 with a result of € -175,235 after tax. For that financial year EU BIOTECH CAMPUS recorded a gross margin of € 89,721 and equity of € 4 million. Compared with financial year 2023, the result moved from € -292,416 to € -175,235. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 18, 2025.
What happened at EU BIOTECH CAMPUS?
What happened at EU BIOTECH CAMPUS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- BIOPARK DEV SA stepped down as director. NBB
- ESSENSCIA ASBL stepped down as director. NBB
- UNIVERCELLS SA stepped down as director. NBB
- LE FOREM EtUtPub stepped down as director. NBB
- BIOWIN ASBL stepped down as director. NBB
- CEFOCHIM/APTASKIL ASBL stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 175,235. filed late Source: NBB ↗
- BIOPARK DEV SA became a director. NBB
In short
From € 34,546 profit in 2022 to € 175,235 loss in 2024.
Best year ever: 2022, with € 34,546 profit.
A new publication or filing at EU BIOTECH CAMPUS? We notify you, reason included.
Follow EU BIOTECH CAMPUSNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2024 annual accounts
Director · represented by Dominique Demonté
since 2024 · until 2028
Chairman of the board · represented by Frédéric DRUCK
Also active at: AKT For Wallonia, FOST PLUS, aptaskil +3 more
since 2021 · until 2025
since 2021 · until 2025
Vice-chairman of the board · represented by Eric VAN SEVENANT
Also active at: MISSION REGIONALE POUR L'INSERTION ET L'EMPLOI A CHARLEROI, MISSION REGIONALE POUR L'EMPLOI ET L'INSERTION DU SUD DE L'ENTRE-SAMBRE-ET-MEUSE, Mission régionale pour l'Insertion et l'Emploi pour Verviers +16 more
since 2021 · until 2025
Director · represented by Mélanie MESTDAGT
since 2021 · until 2025
Director · represented by Thierry JOSEPHY
since 2021 · until 2025
Establishments
Establishment units
Physical locations of this company
Rue Clément Ader 10
6041 Charleroi
Rue Clément Ader 10 box /
6041 Charleroi
Active since 8 January 2024
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
Brussels South Charleroi BioPark Dev same network
€ 80,186 gross margin · 2025
ImmunXperts
€ 393,338 gross margin · 2024
LYS MEDICAL
€ -309,203 gross margin · 2025
SPECTRALYS BIOTECH
€ 143,689 gross margin · 2025
ProtonW.be
€ -7,643 gross margin · 2025
+26 more
Details
- Company number
- 0776.668.706
- VAT number
- BE 0776.668.706
- Registered office
- Rue Clément Ader 10, 6041 Charleroi
- Names & denominations
- EU BIOTECH CAMPUS · EBC
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 29 October 2021
- Peppol
- Active · Active since 5 Dec 2025
- Contact
- didier.j.malherbe@gmail.com
- Activities · NACE
Overige verenigingen, neg
Overige zakelijke dienstverlening, neg